Laboratory Corp. Of America Holdings LH

NYS: LH | ISIN: US50540R4092   11/09/2026
311,54 USD (+1,49%)
(+1,49%)   11/09/2026

10 september 2026 · Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day · Persbericht

9 september 2026 · Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update · Persbericht

8 september 2026 · Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials · Persbericht

31 augustus 2026 · Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity · Persbericht

28 augustus 2026 · Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference · Persbericht

24 augustus 2026 · Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings · Persbericht

18 augustus 2026 · Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health · Persbericht

17 augustus 2026 · Labcorp to Host Investor Day on September 10, 2026 · Persbericht

10 augustus 2026 · Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma · Persbericht

4 augustus 2026 · Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer · Persbericht

30 juli 2026 · Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance · Persbericht

27 juli 2026 · Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing · Persbericht

9 juli 2026 · Labcorp Declares Quarterly Dividend · Persbericht

30 juni 2026 · Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 · Persbericht

22 juni 2026 · Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test · Persbericht

29 mei 2026 · Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer · Persbericht

28 mei 2026 · Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects · Persbericht

27 mei 2026 · Labcorp to Present at the Jefferies Global Healthcare Conference · Persbericht

20 mei 2026 · Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time · Persbericht

12 mei 2026 · Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems · Persbericht

Mijn selecties